Literature DB >> 18050390

Interactions with microbial pathogens.

Creg Darby1.   

Abstract

A wide variety of bacterial pathogens, as well as several fungi, kill C. elegans or produce non-lethal disease symptoms. This allows the nematode to be used as a simple, tractable model host for infectious disease. Human pathogens that affect C. elegans include gram-negative bacteria of genera Burkholderia, Pseudomonas, Salmonella, Serratia and Yersinia; gram-positive bacteria Enterococcus, Staphylococcus and Streptococcus; and the fungus Cryptococcus neoformans. Microbes that are not pathogenic to mammals, such as the insect pathogen Bacillus thuringiensis and the nematode-specific Microbacterium nematophilum, are also studied with C. elegans. Many of the pathogens investigated colonize the C. elegans intestine, and pathology is usually quantified as decreased lifespan of the nematode. A few microbes adhere to the nematode cuticle, while others produce toxins that kill C. elegans without a requirement for whole, live pathogen cells to contact the worm. The rapid growth and short generation time of C. elegans permit extensive screens for mutant pathogens with diminished killing, and some of the factors identified in these screens have been shown to play roles in mammalian infections. Genetic screens for toxin-resistant C. elegans mutants have identified host pathways exploited by bacterial toxins.

Entities:  

Mesh:

Year:  2005        PMID: 18050390      PMCID: PMC4781414          DOI: 10.1895/wormbook.1.21.1

Source DB:  PubMed          Journal:  WormBook        ISSN: 1551-8507


  32 in total

1.  Analysis of the Hox epigenetic code.

Authors:  Zoheir Ezziane
Journal:  World J Clin Oncol       Date:  2012-04-10

2.  Model systems to the rescue: The relationship between aging and innate immunity.

Authors:  Scott Alper
Journal:  Commun Integr Biol       Date:  2010-09

3.  Analysis of the Caenorhabditis elegans innate immune response to Coxiella burnetii.

Authors:  James M Battisti; Lance A Watson; Myo T Naung; Adam M Drobish; Ekaterina Voronina; Michael F Minnick
Journal:  Innate Immun       Date:  2016-11-24       Impact factor: 2.680

4.  (1)H NMR-based metabolic profiling reveals inherent biological variation in yeast and nematode model systems.

Authors:  Samuel S W Szeto; Stacey N Reinke; Bernard D Lemire
Journal:  J Biomol NMR       Date:  2011-02-25       Impact factor: 2.835

Review 5.  Physiological control of germline development.

Authors:  E Jane Albert Hubbard; Dorota Z Korta; Diana Dalfó
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

6.  The type 2 secretion Pseudopilin, gspJ, is required for multihost pathogenicity of Burkholderia cenocepacia AU1054.

Authors:  Vishal S Somvanshi; Poorna Viswanathan; Janette L Jacobs; Martha H Mulks; George W Sundin; Todd A Ciche
Journal:  Infect Immun       Date:  2010-07-26       Impact factor: 3.441

7.  Evaluating the pathogenic potential of environmental Escherichia coli by using the Caenorhabditis elegans infection model.

Authors:  Alexandra Merkx-Jacques; Anja Coors; Roland Brousseau; Luke Masson; Alberto Mazza; Yuan-Ching Tien; Edward Topp
Journal:  Appl Environ Microbiol       Date:  2013-02-01       Impact factor: 4.792

8.  A polymorphism in npr-1 is a behavioral determinant of pathogen susceptibility in C. elegans.

Authors:  Kirthi C Reddy; Erik C Andersen; Leonid Kruglyak; Dennis H Kim
Journal:  Science       Date:  2009-01-16       Impact factor: 47.728

9.  Genetic diversity and multihost pathogenicity of clinical and environmental strains of Burkholderia cenocepacia.

Authors:  A Cody Springman; Janette L Jacobs; Vishal S Somvanshi; George W Sundin; Martha H Mulks; Thomas S Whittam; Poorna Viswanathan; R Lucas Gray; John J Lipuma; Todd A Ciche
Journal:  Appl Environ Microbiol       Date:  2009-06-19       Impact factor: 4.792

Review 10.  Caenorhabditis elegans meets microsporidia: the nematode killers from Paris.

Authors:  Jonathan Hodgkin; Frederick A Partridge
Journal:  PLoS Biol       Date:  2008-12-23       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.